Liquidia Shares Plunge After Court Ruling Invalidates Yutrepia Patent
Liquidia (LQDA) shares fell sharply after a Delaware court ruled that its inhaled drug Yutrepia infringes on two claims of a United Therapeutics (UTHR) patent. The ruling follows a 57% drop in LQDA shares on Wednesday.
Liquidia (LQDA) shares fell again on Thursday after ending Wednesday down 57%, following a Delaware court ruling that said its inhaled drug Yutrepia infringes two claims of a United Therapeutics (UTHR) patent. Both companies sell inhaled treprostinil for two rare lung conditions: pulmonary arteria…